642 related articles for article (PubMed ID: 24807491)
1. Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.
Kuo HC
Int J Urol; 2014 Apr; 21 Suppl 1():34-41. PubMed ID: 24807491
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for interstitial cystitis/painful bladder syndrome.
Argade S; Chermansky C; Tyagi P
Womens Health (Lond); 2016 Jan; 12(1):87-90. PubMed ID: 26696241
[No Abstract] [Full Text] [Related]
3. Editorial comment from Dr. Yoshimura to Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.
Yoshimura N
Int J Urol; 2014 Apr; 21 Suppl 1():42. PubMed ID: 24807493
[No Abstract] [Full Text] [Related]
4. Editorial comment from Dr. Hanno to Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.
Hanno P
Int J Urol; 2014 Apr; 21 Suppl 1():41. PubMed ID: 24807492
[No Abstract] [Full Text] [Related]
5. Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis.
Logadottir Y; Delbro D; Lindholm C; Fall M; Peeker R
Int J Urol; 2014 Apr; 21 Suppl 1():75-8. PubMed ID: 24807505
[TBL] [Abstract][Full Text] [Related]
6. APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.
Zhang CO; Li ZL; Kong CZ
BMC Urol; 2005 Apr; 5():7. PubMed ID: 15862132
[TBL] [Abstract][Full Text] [Related]
7. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis.
Hurst RE; Moldwin RM; Mulholland SG
Urology; 2007 Apr; 69(4 Suppl):17-23. PubMed ID: 17462475
[TBL] [Abstract][Full Text] [Related]
8. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
9. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.
Keay S; Kleinberg M; Zhang CO; Hise MK; Warren JW
J Urol; 2000 Dec; 164(6):2112-8. PubMed ID: 11061938
[TBL] [Abstract][Full Text] [Related]
10. Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Logadottir Y; Delbro D; Fall M; Gjertsson I; Jirholt P; Lindholm C; Peeker R
J Urol; 2014 Nov; 192(5):1564-8. PubMed ID: 24813342
[TBL] [Abstract][Full Text] [Related]
11. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?
Gamper M; Regauer S; Welter J; Eberhard J; Viereck V
J Urol; 2015 Jun; 193(6):1994-2000. PubMed ID: 25596361
[TBL] [Abstract][Full Text] [Related]
12. Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.
Chai TC; Zhang CO; Shoenfelt JL; Johnson HW; Warren JW; Keay S
J Urol; 2000 May; 163(5):1440-4. PubMed ID: 10751853
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis.
Homma Y
Int J Urol; 2014 Apr; 21 Suppl 1():43-7. PubMed ID: 24807494
[TBL] [Abstract][Full Text] [Related]
14. Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells.
Logadottir Y; Hallsberg L; Fall M; Peeker R; Delbro D
Scand J Urol; 2013 Feb; 47(1):52-6. PubMed ID: 22775390
[TBL] [Abstract][Full Text] [Related]
15. Interstitial cystitis is bladder pain syndrome with Hunner's lesion.
Fall M; Logadottir Y; Peeker R
Int J Urol; 2014 Apr; 21 Suppl 1():79-82. PubMed ID: 24807507
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
Jhang JF; Jiang YH; Kuo HC
Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497
[TBL] [Abstract][Full Text] [Related]
17. Voiding diary might serve as a useful tool to understand differences between bladder pain syndrome/interstitial cystitis and overactive bladder.
Kim SH; Oh SA; Oh SJ
Int J Urol; 2014 Feb; 21(2):179-83. PubMed ID: 23841824
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis.
Ogawa T; Homma T; Igawa Y; Seki S; Ishizuka O; Imamura T; Akahane S; Homma Y; Nishizawa O
J Urol; 2010 Mar; 183(3):1206-12. PubMed ID: 20096889
[TBL] [Abstract][Full Text] [Related]
19. A comparison of multiple urine markers for interstitial cystitis.
Erickson DR; Xie SX; Bhavanandan VP; Wheeler MA; Hurst RE; Demers LM; Kushner L; Keay SK
J Urol; 2002 Jun; 167(6):2461-9. PubMed ID: 11992058
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor beta-deficient female mice develop a bladder phenotype resembling human interstitial cystitis.
Imamov O; Yakimchuk K; Morani A; Schwend T; Wada-Hiraike O; Razumov S; Warner M; Gustafsson JA
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9806-9. PubMed ID: 17522255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
